Nicholas Au Yong, MD
Neurological Surgery · Atlanta, GANPI 1407146772
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (49.4%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 60.6% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $16,702, more than ten times the $1,215 reported in 2019.
Across 75 payments — averaging $334.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$15K
- Insightec,inc$5K
- Clearpoint Neuro, Inc.$2K
- Boston Scientific$1K
- Abbott$608
- Neuropace, Inc.$132
- plus $57 from 1 others
What the payments were for
- Consulting fees$10,63942%
- Travel & lodging$12,39049%
- Food & beverage$2,0568%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 29 | $15,201 |
| Insightec,inc | 15 | $5,410 |
| Clearpoint Neuro, Inc. | 12 | $2,215 |
| Boston Scientific | 10 | $1,463 |
| Abbott | 6 | $608 |
| Neuropace, Inc. | 1 | $132 |
| Medical Device Business Services, Inc. | 2 | $57 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STEALTHSTATION S8 PLATFORM$12,463
- Exablate$5,192
- CLEARPOINT$2,053
- ACTIVA PC$2,015
- GENERAL DBS$997
- INFINITY$527
- GENERAL PAIN MANAGEMENT$150
- RNS Neurostimulator Kit$132
How this compares
$25,086 in reported general payments places this provider in the 80th percentile of 201 neurological surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 28 | $298 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $115 |
| Tramadol Hcl | 16 | $15 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Atlanta
- Regis HaidAtlanta$25.5M
- Thomas MorrisonAtlanta$2.8M
- Christopher TomarasAtlanta$1.5M
- Daniel RefaiAtlanta$1.2M
- Gerald RodtsAtlanta$1.2M
- James RobinsonAtlanta$993K
- Michele JohnsonAtlanta$540K
- David McCrackenAtlanta$425K
- Robert GrossAtlanta$315K
- Kaveh KhajaviAtlanta$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.